Position in XLO
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$891,308
-$12,403,163 QoQ
Shares Held
105,982
-92.9% QoQ
Ownership
1.83%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#6
of 21 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in XLO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Merck & Co., Inc. holds $226,666,774 across 9 Biotechnology names. XLO ranks #7 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
2,308,190 | $117,256,052 | |
| 2 | KYMR |
Kymera Therapeutics, Inc.
|
772,165 | $64,313,622 | |
| 3 | EIKN |
Eikon Therapeutics, Inc.
|
1,666,666 | $17,633,326 | |
| 4 | AKTS |
Aktis Oncology, Inc.
|
952,844 | $17,046,379 | |
| 5 | ALEC |
Alector, Inc.
|
3,545,719 | $7,623,295 | |
| 6 | VRDN |
Viridian Therapeutics, Inc.\DE
|
93,414 | $1,827,177 | |
| 7 | XLO |
Xilio Therapeutics, Inc.
This page
|
105,982 | $891,308 | |
| 8 | NEUP |
Neuphoria Therapeutics Inc.
|
10,027 | $40,809 |
All Filings in XLO
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $891,308 | 105,982 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $13,294,471 | 1,483,758 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $17,511,311 | 1,483,758 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $14,125,376 | 1,483,758 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $15,039,371 | 1,483,758 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $19,837,844 | 1,483,758 | Shares | Defined | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||